- Home
- CCI vs ALC Comparison
CCI vs ALC Comparison
Compare CCI & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCI
- ALC
- Stock Information
- Founded
- CCI 1994
- ALC 1945
- Country
- CCI United States
- ALC Switzerland
- Employees
- CCI N/A
- ALC N/A
- Industry
- CCI Real Estate Investment Trusts
- ALC Ophthalmic Goods
- Sector
- CCI Real Estate
- ALC Health Care
- Exchange
- CCI Nasdaq
- ALC Nasdaq
- Market Cap
- CCI 45.5B
- ALC 40.2B
- IPO Year
- CCI 1998
- ALC N/A
- Fundamental
- Price
- CCI $98.43
- ALC $76.25
- Analyst Decision
- CCI Buy
- ALC Buy
- Analyst Count
- CCI 16
- ALC 11
- Target Price
- CCI $118.13
- ALC $91.41
- AVG Volume (30 Days)
- CCI 2.7M
- ALC 2.3M
- Earning Date
- CCI 10-22-2025
- ALC 11-11-2025
- Dividend Yield
- CCI 4.32%
- ALC 0.28%
- EPS Growth
- CCI N/A
- ALC N/A
- EPS
- CCI N/A
- ALC 2.16
- Revenue
- CCI $6,420,000,000.00
- ALC $10,025,000,000.00
- Revenue This Year
- CCI N/A
- ALC $5.94
- Revenue Next Year
- CCI $2.51
- ALC $7.71
- P/E Ratio
- CCI N/A
- ALC $35.42
- Revenue Growth
- CCI 15.74
- ALC 4.04
- 52 Week Low
- CCI $84.20
- ALC $71.55
- 52 Week High
- CCI $115.76
- ALC $99.20
- Technical
- Relative Strength Index (RSI)
- CCI 55.24
- ALC 50.22
- Support Level
- CCI $95.34
- ALC $71.55
- Resistance Level
- CCI $100.50
- ALC $76.09
- Average True Range (ATR)
- CCI 2.03
- ALC 1.27
- MACD
- CCI 0.38
- ALC 0.51
- Stochastic Oscillator
- CCI 71.26
- ALC 86.08
About CCI Crown Castle Inc.
Crown Castle owns and leases roughly 40,000 cell towers in the United States. It also owns more than 90,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. Crown Castle's towers and fiber are predominantly in the largest US cities. The company has a very concentrated customer base, with about 75% of its revenue from the Big Three US mobile carriers. Crown Castle operates as a real estate investment trust. It has announced plans to divest its fiber business, which should be finalized in 2026. After that, Crown will be a stand-alone tower operator.
About ALC Alcon Inc.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.